Case reports of individual patients suggestive of overlap autoimmune diseases triggered by parvovirus B19 infection
| Reference | Age (years) | Sex | Autoimmune diseases | Autoantibodies | Interval between B19 infection and autoimmune disease (days) |
|---|---|---|---|---|---|
| 186 | 40 | F | Rheumatoid arthritis, type 1 diabetes mellitus, Graves disease | Rheumatoid factor Anti-GAD, high level Anti-TSH | 0 |
| 210 | 8 | M | Polyarthritis, pneumonitis, glomuerlonephritis | – | 15 |
| 211 | 9 | F | Systemic lupus erythematosus, glomerulonephritis, encephalopathy | Nucleolar ANA 1:400 Anti-dsDNA ≥1:320 Anti-cardiolipin IgM | 0 |
| 113 | 14 | M | Hepatitis, myositis | – | 24 |
| 102 | 19 | M | Still’s disease, immune thrombocytopenic purpura, hepatitis | – | 30 |
| 212 | 1.5 | F | Myocarditis, encephalitis, colitis, hepatitis, immune thrombocytopenic purpura, disseminated intravascular coagulation | – | 0 |
| 121 | 7 | F | Interstitial lung disease, hepatitis, myositis | Homogenous nucleolar ANA 1:160 Anti-SS-A | 60 |
| 213 | 18 | M | Arthritis, hepatitis | ? | 0 |
| 214 | 41 | M | Hepatitis, arthritis | Anti-cyclic citrullinated peptide antibody | 14 |
| 162 | 33 | F | Neuralgic amyotrophy, polyarthritis | – | 3 |
| 215 | 28 | F | Retinal detachment, aplastic anaemia | – | 60 |
| 123 | 65 | F | Arthritis, hepatitis, myositis, pleural effusion, pericardial effusion, cardiomyopathy | Transient ANA | 0 |
ANA, anti-nuclear antibody; GAD, glutamic acid decarboxylase; TSH, thyroid-stimulating hormone.